Ray–

It just goes to show that if one truly wants to make a paradigm change in the standard of care (versus the sale of a few lasers) one must be dedicated to conducting high quality science on an ongoing basis as a misson statement of the company’s purpose.

That’s why MDT focuses on one very specific and stubborn disease process that has resisted all efforts to address it.

It isn’t easy to tame the skeptics who jealously guard their turf.

But what has happend, is the requirements to satisfy the skeptics are getting more narrowed down.  We have made major milestones in addressing the skeptics’ concerns since 1990, over safety at first, then equivalence to gold standard, now we have pushed that to a point where we are arging over LANAP as a complete replacement for conventional perio intervention (substractive surgery)–that is–superiority and a true paradigm shift from the old to a new paradigm for perio.

Dr. Douglas is not dismissing Yuka’s work, but calling for clinical studies that MDT has already designed with Yukna at LSU and Cobb at UMKC.

We understand the skeptics, the opposition and the lay of the land, and we are executing our strategy to overcome them all.  All it takes is time, money…….and patience………all while fending off sometimes whithering personal and professional attacks from skeptics, and competitor claims that “we can do what they can do” kind of stuff.

If history is any lesson, Del and I as clinicians and MDT as a company, have outlasted and outperformed many of the very critics and competitors who said we and our work and our focus was too narrow and we were not to be taken seriously.

Only time will tell if we make any lasting change.

Bob

Thanks Andrew,

I appreciate the kinds words.

We’re working on CSA.

All any of us can do is set worthwhile goals and take measured steps to achieve them……..

Cheers!

Bob

Bruce,

Call me and I can help you with that. Any MDT customers too.

I’ll be providing some info some that will help all of you next week this time.

Bob